Fig. 5

A: Kaplan Meier curves comparing RFS between patients with pathologically confirmed cholangiocyte phenotype-positive HCC (cholangiocyte phenotype +) and classical HCC groups (cholangiocyte phenotype -). B: Kaplan Meier curves comparing RFS between patients with XGBoost calculated high-risk and low-risk groups